Keith Szymanski

416 total citations
11 papers, 352 citations indexed

About

Keith Szymanski is a scholar working on Nephrology, Pharmacology and Genetics. According to data from OpenAlex, Keith Szymanski has authored 11 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Nephrology, 2 papers in Pharmacology and 2 papers in Genetics. Recurrent topics in Keith Szymanski's work include Chronic Lymphocytic Leukemia Research (2 papers), Medication Adherence and Compliance (2 papers) and Gout, Hyperuricemia, Uric Acid (2 papers). Keith Szymanski is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Medication Adherence and Compliance (2 papers) and Gout, Hyperuricemia, Uric Acid (2 papers). Keith Szymanski collaborates with scholars based in United States, Japan and Poland. Keith Szymanski's co-authors include Gary D. Tollefson, Bruce J. Kinon, Bruce R. Basson, Cindy C. Taylor, J. A. Gilmore, Charles L. Baum, Eric Wittbrodt, Lizheng Shi, Vivian Fonseca and Yingnan Zhao and has published in prestigious journals such as Blood, American Journal of Respiratory and Critical Care Medicine and The Journal of Clinical Psychiatry.

In The Last Decade

Keith Szymanski

10 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keith Szymanski United States	7	200	127	77	46	45	11	352
Euderruh Uzcátegui Venezuela	11	288 1.4×	173 1.4×	166 2.2×	65 1.4×	35 0.8×	13	475
Frederik Vandenberghe Switzerland	10	148 0.7×	87 0.7×	60 0.8×	47 1.0×	16 0.4×	33	302
Ana Serrano Venezuela	12	241 1.2×	140 1.1×	148 1.9×	53 1.2×	16 0.4×	25	476
Silvia Donati Italy	8	283 1.4×	41 0.3×	248 3.2×	59 1.3×	26 0.6×	8	505
Huai Heng Loh Malaysia	12	55 0.3×	98 0.8×	179 2.3×	17 0.4×	29 0.6×	32	388
A. Boshier United Kingdom	10	74 0.4×	103 0.8×	31 0.4×	52 1.1×	19 0.4×	10	382
Ann Verhaegen Belgium	9	41 0.2×	82 0.6×	91 1.2×	36 0.8×	12 0.3×	22	296
John Pendlebury United Kingdom	12	318 1.6×	121 1.0×	116 1.5×	19 0.4×	6 0.1×	16	505
Paul S. Mueller United States	7	61 0.3×	106 0.8×	61 0.8×	81 1.8×	40 0.9×	16	412
R. Ness-Abramof Israel	12	38 0.2×	172 1.4×	217 2.8×	58 1.3×	28 0.6×	37	569

Countries citing papers authored by Keith Szymanski

Since Specialization

Citations

This map shows the geographic impact of Keith Szymanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Szymanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Szymanski more than expected).

Fields of papers citing papers by Keith Szymanski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Szymanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Szymanski. The network helps show where Keith Szymanski may publish in the future.

Co-authorship network of co-authors of Keith Szymanski

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Szymanski. A scholar is included among the top collaborators of Keith Szymanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Szymanski. Keith Szymanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Sethi, Sanjay, Hayley D. Germack, Laurence Gozalo, et al.. (2025). Real-World Effectiveness of Budesonide/Glycopyrrolate/Formoterol Fumarate on COPD Exacerbation-Related Healthcare Utilization and Costs: Results from the US Arctos Study. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A2096–A2096.

Hou, Jing‐Zhou, Kellie Ryan, Bruno Fang, et al.. (2021). Real-World Ibrutinib dose Reductions, Holds and Discontinuations in Chronic Lymphocytic Leukemia. Future Oncology. 17(35). 4959–4969. 17 indexed citations

Hou, Jing‐Zhou, Kellie Ryan, Bruno Fang, et al.. (2020). Dose Reductions and Discontinuations with Chronic Lymphocytic Leukemia (CLL) Patients Receiving Ibrutinib in Community and Academic Settings. Blood. 136(Supplement 1). 12–13. 1 indexed citations

Klein, Robert W., et al.. (2018). Budget impact of adding lesinurad for second-line treatment of gout: a US health plan perspective. Journal of Comparative Effectiveness Research. 7(8). 807–816. 2 indexed citations

Szymanski, Keith, et al.. (2017). Predictors of reaching a serum uric acid goal in patients with gout and treated with febuxostat. ClinicoEconomics and Outcomes Research. Volume 9. 629–639. 13 indexed citations

Baum, Charles L., et al.. (2015). The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA. PharmacoEconomics. 33(7). 643–653. 31 indexed citations

Pringle, Janice L., et al.. (2015). User testing and performance evaluation of the Electronic Quality Improvement Platform for Plans and Pharmacies. Journal of the American Pharmacists Association. 55(6). 634–641. 4 indexed citations

Egan, Brent M., Stephanie R. Shaftman, C. Shaun Wagner, Dipankar Bandyopadhyay, & Keith Szymanski. (2012). Demographic differences in the treatment and control of glucose in type 2 diabetic patients: implications for health care practice.. PubMed. 22(1). 29–37. 11 indexed citations

Shi, Lizheng, Yingnan Zhao, Keith Szymanski, Lillian Yau, & Vivian Fonseca. (2010). Impact of thiazolidinedione safety warnings on medication use patterns and glycemic control among veterans with diabetes mellitus. Journal of Diabetes and its Complications. 25(3). 143–150. 16 indexed citations

10.

Basson, Bruce R., Bruce J. Kinon, Cindy C. Taylor, et al.. (2001). Factors Influencing Acute Weight Change in Patients With Schizophrenia Treated With Olanzapine, Haloperidol, or Risperidone. The Journal of Clinical Psychiatry. 62(4). 231–238. 248 indexed citations

11.

Kinon, Bruce J., Bruce R. Basson, Keith Szymanski, & Gary D. Tollefson. (1998). Predictors of weight gain during olanzapine treatment. European Neuropsychopharmacology. 8. S220–S220. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact